Tech Center 1600 • Art Units: 1621 1628 1632 1634 1682
This examiner grants 24% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17653114 | Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18166782 | LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17907837 | EPITHELIAL CELL TUBE FOR TRACHEAL TRANSPLANTATION | Final Rejection | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17919364 | Methods for Extending the Shelf-life of Stored Donor Blood and/or Red Blood Cells and Treated Red Blood Cell Compositions Produced Thereby | Non-Final OA | Ohio University |
| 17779783 | AN ACELLULAR NERVE GRAFT | Non-Final OA | ROYAL COLLEGE OF SURGEONS IN IRELAND |
| 17915232 | METHOD FOR EDITING TARGET RNA | Final Rejection | EditForce, Inc. |
| 18001259 | THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY DISEASES | Non-Final OA | Shanghai Seme Cell Technology Co., Ltd. |
| 17916166 | COMPOSITION | Non-Final OA | INOCELLS B.V. |
| 17911930 | RECOMBINANT PROTEIN PRODUCTION IN INSECTS | Final Rejection | Proteinea, Inc. |
| 17608422 | A Method for Predicting Prognosis of Cancer and the Composition Thereof | Final Rejection | DCGEN CO, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy